Catalyst Wire Dossier Catalyst Wire Dossier

PG-011 Gel

· Prime Gene Therapeutics Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PG-011 Gel, covering 2025-05-20 to 2025-05-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of PG-011 Gel in Adolescents and Adults With Atopic Dermatitis [Phase 3]

See pricing